Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q1 2021 · 10-Q
Revenue$12.24M$12.24M−3.7% vs Q1 2020 Net Income-$9.28M-$9.28MN/M vs Q1 2020 EPS Diluted-$1.40-$1.40N/M vs Q1 2020 Gross Profit$2,463,000+13.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flow-$8,197,000N/M Margins · derivedGross margin20.1%+3.1 pt vs Q1 2020
Operating margin-73.9%−2.6 pt vs Q1 2020
Net margin-75.8%+2.6 pt vs Q1 2020
ended Mar 31, 2021 · filed May 11, 2021 · 41 d after period end